Skip to main content
Premium Trial:

Request an Annual Quote

LifeSpan, Pfizer to Co-develop Automated Pathology System

NEW YORK, March 3 (GenomeWeb News) - LifeSpan BioSciences and Pfizer will co-develop an automated tissue pathology-analysis system for use in preclinical studies, the companies said today.

 

"The primary goal is to develop a product that Pfizer will use in their research," said Joe Brown, LifeSpan president and CEO.

 

He said the company would not yet disclose whether the product would be available on the general market, and declined to disclose financial terms of the deal. However, he said that Pfizer would be providing financial support for the project.

 

Based on LifeSpan's Alias system, the product will use "enhanced image capture and artificial intelligence analysis software to evaluate stained tissue specimens for quality and tissue abnormalities," the companies said.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.